“Zanubrutinib as upfront treatment in de-novo B-cell prolymphocytic leukemia: the case of two elderlies”., Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025061, Aug. 2025, doi: 10.4084/MJHID.2025.061.